Ketamine and other NMDA receptor antagonists for chronic pain

Author:

Ferraro Michael C12,Cashin Aidan G12,O'Connell Neil E3,Visser Eric J.4,Abdel Shaheed Christina5,Wewege Michael A12,Gustin Sylvia M1,McAuley James H12

Affiliation:

1. Centre for Pain IMPACT; Neuroscience Research Australia; Sydney Australia

2. School of Health Sciences, Faculty of Medicine and Health; University of New South Wales; Sydney Australia

3. Department of Health Sciences, Centre for Health and Wellbeing Across the Lifecourse; Brunel University London; Uxbridge UK

4. School of Medicine; University of Notre Dame Australia; Fremantle Australia

5. Institute for Musculoskeletal Health, Sydney School of Public Health; Faculty of Medicine and Health, The University of Sydney; Sydney Australia

Publisher

Wiley

Subject

Pharmacology (medical)

Reference66 articles.

1. Ketamine infusion therapy for chronic pain management in South Korea: a national survey for pain physicians with a narrative review;Anaya;Medicine (Baltimore),2018

2. Position Statement on the use of ketamine in the management of chronic non-cancer pain www.anzca.edu.au/getattachment/f2fbc568-aa5f-4d64-993f-fca8b230603d/PS12(PM)-Position-statement-on-the-use-of-ketamine-in-the-management-of-chronic-non-cancer-pain-PILOT 2021

3. Ketamine as an adjuvant to opioids for cancer pain;Bell;Cochrane Database of Systematic Reviews,2017

4. Ketamine for pain management;Bell;Pain Reports,2018

5. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment;Breivik;European Journal of Pain,2006

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3